Cargando…

Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets

The present investigation deals with development of mouth disintegrating tablets of rizatriptan benzoate to produce the intended benefits. Mouth disintegrating tablets of rizatriptan benzoate were prepared using superdisintegrants crospovidone, carboxymethylcellulose calcium, Indion 414 and Indion 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Keny, R. V., Desouza, Chrisma, Lourenco, C. F.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883231/
https://www.ncbi.nlm.nih.gov/pubmed/20582194
http://dx.doi.org/10.4103/0250-474X.62253
_version_ 1782182248802418688
author Keny, R. V.
Desouza, Chrisma
Lourenco, C. F.
author_facet Keny, R. V.
Desouza, Chrisma
Lourenco, C. F.
author_sort Keny, R. V.
collection PubMed
description The present investigation deals with development of mouth disintegrating tablets of rizatriptan benzoate to produce the intended benefits. Mouth disintegrating tablets of rizatriptan benzoate were prepared using superdisintegrants crospovidone, carboxymethylcellulose calcium, Indion 414 and Indion 234 using the direct compression method. The tablets prepared were evaluated for thickness, uniformity of weight, content uniformity, hardness, friability, wetting time, in vitro and in vivo disintegration time, mouth feel, in vitro drug release and assay by high performance liquid chromatography. The tablets disintegrated in vitro and in vivo within 4 to 7 s and 6 to 19 s, respectively. Almost 90% of drug was released from all formulations within 20 min. The drug release from the formulations followed first order kinetics. Stability studies of the tablets at 40±2°/75%±5% RH for 1 mo showed non significant drug loss. The formulation containing combination of crospovidone and Indion 234 was found to give the best results. Apart from fulfilling all official and other specifications, the tablets exhibited higher rate of release.
format Text
id pubmed-2883231
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28832312010-06-25 Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets Keny, R. V. Desouza, Chrisma Lourenco, C. F. Indian J Pharm Sci Research Paper The present investigation deals with development of mouth disintegrating tablets of rizatriptan benzoate to produce the intended benefits. Mouth disintegrating tablets of rizatriptan benzoate were prepared using superdisintegrants crospovidone, carboxymethylcellulose calcium, Indion 414 and Indion 234 using the direct compression method. The tablets prepared were evaluated for thickness, uniformity of weight, content uniformity, hardness, friability, wetting time, in vitro and in vivo disintegration time, mouth feel, in vitro drug release and assay by high performance liquid chromatography. The tablets disintegrated in vitro and in vivo within 4 to 7 s and 6 to 19 s, respectively. Almost 90% of drug was released from all formulations within 20 min. The drug release from the formulations followed first order kinetics. Stability studies of the tablets at 40±2°/75%±5% RH for 1 mo showed non significant drug loss. The formulation containing combination of crospovidone and Indion 234 was found to give the best results. Apart from fulfilling all official and other specifications, the tablets exhibited higher rate of release. Medknow Publications 2010 /pmc/articles/PMC2883231/ /pubmed/20582194 http://dx.doi.org/10.4103/0250-474X.62253 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Keny, R. V.
Desouza, Chrisma
Lourenco, C. F.
Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets
title Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets
title_full Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets
title_fullStr Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets
title_full_unstemmed Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets
title_short Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets
title_sort formulation and evaluation of rizatriptan benzoate mouth disintegrating tablets
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883231/
https://www.ncbi.nlm.nih.gov/pubmed/20582194
http://dx.doi.org/10.4103/0250-474X.62253
work_keys_str_mv AT kenyrv formulationandevaluationofrizatriptanbenzoatemouthdisintegratingtablets
AT desouzachrisma formulationandevaluationofrizatriptanbenzoatemouthdisintegratingtablets
AT lourencocf formulationandevaluationofrizatriptanbenzoatemouthdisintegratingtablets